12,987 reports of this reaction
6.3% of all BEVACIZUMAB reports
#2 most reported adverse reaction
DEATH is the #2 most commonly reported adverse reaction for BEVACIZUMAB, manufactured by Genentech, Inc.. There are 12,987 FDA adverse event reports linking BEVACIZUMAB to DEATH. This represents approximately 6.3% of all 204,762 adverse event reports for this drug.
Patients taking BEVACIZUMAB who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEATH is moderately reported among BEVACIZUMAB users, representing a notable but not dominant share of adverse events.
In addition to death, the following adverse reactions have been reported for BEVACIZUMAB:
The following drugs have also been linked to death in FDA adverse event reports:
DEATH has been reported as an adverse event in 12,987 FDA reports for BEVACIZUMAB. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEATH accounts for approximately 6.3% of all adverse event reports for BEVACIZUMAB, making it one of the most commonly reported side effect.
If you experience death while taking BEVACIZUMAB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.